Elutia Inc. (ELUT)
NASDAQ: ELUT · Real-Time Price · USD
0.8951
-0.0471 (-5.00%)
At close: Nov 7, 2025, 4:00 PM EST
0.8701
-0.0250 (-2.79%)
After-hours: Nov 7, 2025, 4:35 PM EST
Elutia Market Cap
Elutia has a market cap or net worth of $37.95 million as of November 7, 2025. Its market cap has decreased by -64.52% in one year.
Market Cap
37.95M
Enterprise Value
59.55M
1-Year Change
-64.52%
Ranking
Category
Stock Price
$0.90
Market Cap Chart
Since the IPO on October 8, 2020, Elutia's market cap has decreased from $173.84M to $37.95M, a decrease of -78.17%. That is a compound annual growth rate of -25.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 7, 2025 | 37.95M | -70.64% |
| Dec 31, 2024 | 129.26M | 157.97% |
| Dec 29, 2023 | 50.11M | -26.88% |
| Dec 30, 2022 | 68.53M | -19.77% |
| Dec 31, 2021 | 85.42M | -38.72% |
| Dec 31, 2020 | 139.38M | -19.82% |
| Oct 8, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 839.37B |
| Johnson & Johnson | 450.47B |
| AbbVie | 387.13B |
| UnitedHealth Group | 291.28B |
| AstraZeneca | 251.76B |
| Novartis AG | 242.27B |
| Abbott Laboratories | 217.27B |
| Merck & Co. | 213.01B |